Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Stahl A, Azuma N, Wu WC, Lepore D, Sukgen E, Nakanishi H, Mazela J, Leal S, Pieper A, Schlief S, Eissing T, Turner KC, Zhao A, Winkler J, Höchel J, Köfüncü E, Zimmermann T; FIREFLEYE Study Group. Stahl A, et al. Among authors: lepore d. Eye (Lond). 2024 Jun;38(8):1444-1453. doi: 10.1038/s41433-023-02919-9. Epub 2024 Jan 10. Eye (Lond). 2024. PMID: 38200320 Free PMC article. Clinical Trial.
Abnormal retinal vascularisation in preterm children.
Minicucci G, Lepore D, Molle F. Minicucci G, et al. Among authors: lepore d. Lancet. 1999 Mar 27;353(9158):1099-100. doi: 10.1016/S0140-6736(05)76457-6. Lancet. 1999. PMID: 10199376 No abstract available.
[Ocular anomalies in Alagille's syndrome].
Ricci B, Lepore D, Iossa M, Santo A, Chiaretti A. Ricci B, et al. Among authors: lepore d. J Fr Ophtalmol. 1991;14(8-9):481-5. J Fr Ophtalmol. 1991. PMID: 1779119 French.
Taurine and diabetes. Humans and experimental models.
Franconi F, Miceli M, Fazzini A, Seghieri G, Caputo S, DiLeo MA, Lepore D, Ghirlanda G. Franconi F, et al. Among authors: lepore d. Adv Exp Med Biol. 1996;403:579-82. Adv Exp Med Biol. 1996. PMID: 8915396 No abstract available.
Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial.
Fidler M, Fleck BW, Stahl A, Marlow N, Chastain JE, Li J, Lepore D, Reynolds JD, Chiang MF, Fielder AR; RAINBOW study group†. Fidler M, et al. Among authors: lepore d. Transl Vis Sci Technol. 2020 Jul 29;9(8):43. doi: 10.1167/tvst.9.8.43. eCollection 2020 Jul. Transl Vis Sci Technol. 2020. PMID: 32855889 Free PMC article.
International Classification of Retinopathy of Prematurity, Third Edition.
Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, Binenbaum G, Blair M, Peter Campbell J, Capone A Jr, Chen Y, Dai S, Ells A, Fleck BW, Good WV, Elizabeth Hartnett M, Holmstrom G, Kusaka S, Kychenthal A, Lepore D, Lorenz B, Martinez-Castellanos MA, Özdek Ş, Ademola-Popoola D, Reynolds JD, Shah PK, Shapiro M, Stahl A, Toth C, Vinekar A, Visser L, Wallace DK, Wu WC, Zhao P, Zin A. Chiang MF, et al. Among authors: lepore d. Ophthalmology. 2021 Oct;128(10):e51-e68. doi: 10.1016/j.ophtha.2021.05.031. Epub 2021 Jul 8. Ophthalmology. 2021. PMID: 34247850 Free PMC article. Review.
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial.
Marlow N, Stahl A, Lepore D, Fielder A, Reynolds JD, Zhu Q, Weisberger A, Stiehl DP, Fleck B; RAINBOW investigators group. Marlow N, et al. Among authors: lepore d. Lancet Child Adolesc Health. 2021 Oct;5(10):698-707. doi: 10.1016/S2352-4642(21)00195-4. Epub 2021 Aug 13. Lancet Child Adolesc Health. 2021. PMID: 34391532 Clinical Trial.
100 results